StockStorm.ai

Charles River Laboratories International, Inc.

CRL Stock News

Latest CRL news

PGNY vs. CRL: Which Stock Is the Better Value Option?

Zacks Investment Research · Fri, 18 Sep 2026 12:40:55 -0400

Investors looking for stocks in the Medical Services sector might want to consider either Progyny (PGNY) or Charles River Laboratories (CRL). But which of these two stocks presents investors with the better value opportunity right now?

Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines

Business Wire · Thu, 17 Sep 2026 08:00:00 -0400

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) has introduced rapid cell banking programs designed to significantly accelerate release timelines, enabling biopharmaceutical and advanced therapy developers to reach critical milestones faster and bring innovative treatments to patients sooner. By combining rapid cell bank and release packages with advanced characterization using Next-Generation Sequencing (NGS), Charles River delivers a comprehensiv.

Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

Business Wire · Tue, 08 Sep 2026 08:00:00 -0400

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) has successfully implemented its Endosafe® Cartridge Technology Automated Manufacturing Suite, a significant advancement in bacterial endotoxin testing cartridge production that expands in-process inspection and digital traceability, strengthens manufacturing controls and increases production capacity. Reaching full operational capacity in Q3 2026, the automated suite is a major investment in advanced.

Market information is provided for research and visualization and is not investment advice.